Annual Global Discovery to Development Innovation Forum Speakers
Vice President, Head of Chemistry
Dr. Stephanos Ioannidis obtained his B.Sc. at King's College London in chemistry and biochemistry before moving to Imperial College London where he received his PhD in organic chemistry under the supervision of Professor Donald Craig. Following his PhD work, Dr. Ioannidis joined the laboratory of Professor Yoshito Kishi at Harvard University as a post-doctoral fellow. He joined AstraZeneca in Waltham, MA. At AstraZeneca where he led several drug discovery teams at all stages of the pipeline, from target validation stages to the clinic.
In 2013, after more than 11 years of a successful career at AstraZeneca, Dr. Ioannidis moved to FORMA Therapeutics in Watertown, MA. At FORMA Therapeutics, Dr. Ioannidis was the leader of the protein homeostasis area and his responsibilities spun from Director of Medicinal Chemistry to subsequently being the Head of Early Portfolio covering the areas of oncology, immunology/inflammation and neuroscience. Since 2019, Dr. Ioannidis has moved to H3 Biomedicine as the Vice President of Chemistry, DMPK & Safety leading the strategy and drug optimization efforts.